Resultados de la búsqueda 81-90 of 21526 for Treatment
Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...
The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel ...
Personalized Neoantigen Peptide-Based Vaccine In Combination With Pembrolizumab For Treatment Of Advanced Solid Tumors. Jacksonville, Fla. This phase I/II ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). ... treatment and may reduce the burden of cancer and ...
... treatment, post-treatment and (when available) post-mortem soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs occurring in younger ...
-Collect data, images, from patients undergoing surgical treatment of hip disorders (we will not be collecting social security numbers to send to Washington ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). ... treatment, post-treatment and (when available) post ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
... treatment (refractory). Testing The Addition Of Abemaciclib To Olaparib For Women With Recurrent Ovarian Cancer. Jacksonville, Fla., Rochester, Minn ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?